X
More than 60,000 patients use Brite
4.6 stars
Your health finally understandable with Brite
1
Enter email and you're done. No subscription, no credit card.
2
Search, tap and you're done. Over 3,400 medicines.
3
Check, remind, get an overview.
Sarah K., 34
I finally understand my therapy. The app reminds me, answers my questions — and I don't feel alone with it anymore.
At a glance
Instillation dates, supportive medicines and cystoscopies in one place — free in the brite app.
Bladder cancer is a malignant tumour that starts in the inner lining of the bladder. This lining is called the urothelium; it also lines the renal pelvis, the ureters and the urethra. That is why by far the most common type is urothelial carcinoma. Bladder cancer mainly affects older people, and men develop it several times more often than women.¹,²
The typical first sign is blood in the urine that does not hurt. Because it often disappears on its own after a few days, it is easily dismissed. That is exactly what this article is about: painless does not mean harmless. How to make sense of reddish urine in general — from beetroot to kidney stones — is explained in the symptom article Blood in urine. Here the focus is on the disease itself: diagnosis, treatment and life afterwards.
For treatment and prognosis, one question matters above all: has the tumour grown into the muscle layer of the bladder wall or not?³
| Type | What this means | Typical treatment |
|---|---|---|
| Non-muscle-invasive, papillary (Ta, T1) | Grows into the bladder like a small cauliflower; Ta only in the lining, T1 into the connective tissue beneath it | Removal through the urethra (TURBT), bladder instillations depending on risk |
| Carcinoma in situ (CIS) | A flat change in the lining that is hard to see, but aggressive | BCG instillations; if they fail, often removal of the bladder |
| Muscle-invasive (T2 and above) | The tumour reaches into the bladder muscle or beyond | Removal of the bladder with chemotherapy, or bladder-sparing chemoradiotherapy |
| Metastatic | Secondary tumours in lymph nodes, bones, lungs or liver | Systemic treatment, for example an antibody-drug conjugate plus immunotherapy |
In addition, the pathologist assesses the grade: “low grade” grows slowly and often comes back but rarely progresses; “high grade” is more aggressive. Stage, grade, size, the number of tumours and whether CIS is present together give a risk group (low, intermediate, high, very high), which determines follow-up treatment and the intervals between check-ups.³,⁴ Rare types such as squamous cell carcinoma or adenocarcinoma of the bladder are sometimes treated differently.
Most of these symptoms have more harmless causes. The following table shows how common triggers differ — but it does not replace a medical assessment.¹
| Observation | Possible cause | Assessment |
|---|---|---|
| Blood in the urine, no pain, no fever | Bladder tumour, kidney tumour, prostate | Always have it checked by a urologist, even if it stops |
| Blood with burning and a frequent urge to pass urine | Urinary tract infection | Have your urine tested; once it has healed, check that the blood has gone |
| Blood with colicky pain in the flank or groin | Kidney stones | See a doctor; immediately if you have a fever |
| Blood in men with a weak stream | Enlarged prostate | A common cause, but a tumour still has to be ruled out |
| Red-orange or dark brown urine with no blood on the test | Foods (beetroot) or medicines | Harmless if the dipstick shows no blood |
Conversely, some medicines colour the urine without any blood being present: for example nitrofurantoin (yellow-brown), metronidazole and levodopa (dark) or the tuberculosis medicine rifampicin (orange-red). A dipstick test at the practice quickly tells the difference.
The kidneys excrete many harmful substances in the urine, which then sits in the bladder for hours. Cancer-causing substances therefore act directly on the lining. The most important risk factors:¹,³
In women, bladder cancer is on average discovered later, because blood in the urine is often first put down to cystitis or to their period. A “bladder infection” that does not clear up despite an antibiotic, or keeps coming back without any bacteria being found, therefore needs to be investigated more closely.¹
According to the guideline, any visible bleeding in the urine should be investigated by a urologist. Invisible blood is investigated depending on age and risk profile. There is no general screening for bladder cancer.³
To put it honestly: urine tests for so-called tumour markers are sometimes offered as self-pay services. According to the guideline, they cannot replace cystoscopy and are not suitable for early detection in people without symptoms.³ Before the TURBT, the team will discuss whether and when blood thinners are paused — that is for the treatment team to decide; see also Medications before surgery. For the first consultation, the guide Preparing for a doctor’s appointment will help.
Around three quarters of bladder tumours are discovered at this stage. Treatment has two aims: to remove the tumour completely, and to prevent relapses and progression into the muscle layer. Which steps follow the TURBT depends on the risk group.³,⁴
To put it honestly: even with the best treatment, non-muscle-invasive tumours often come back — usually superficial again and readily treatable. That is why years of follow-up with cystoscopies are not a sign of mistrust but part of the treatment. Which option suits you is decided by the treatment team together with you; a second opinion before removal of the bladder is expressly your right.³
If the tumour has grown into the muscle layer, removal through the urethra is no longer enough. Treatment belongs in an experienced centre and is planned at a tumour board.³
Depending on the stage, instillations, infusions, immunotherapy and many supportive medicines come together. What matters most:⁷
Interactions are hard to keep track of with cancer treatments, especially as many of those affected are older and already take several long-term medicines. So always raise St John’s wort, high-dose supplements and any new over-the-counter preparations beforehand; the guide Drug interactions is a good place to start. The choice and dose of every medicine is decided by the treatment team.
brite reminds you of instillations, anti-sickness tablets and check-up appointments.
After removal of the bladder, urine needs a new route out. Which urinary diversion is an option depends on the extent of the tumour, kidney function, age and your own wishes. A thorough consultation before the operation, including with a stoma nurse, is important.³
| Urinary diversion | Principle | In everyday life |
|---|---|---|
| Ileal conduit (urostomy) | A short piece of small intestine carries the urine out through an opening in the abdominal wall | Urine drains continuously into a bag; technically simpler, fewer metabolic effects |
| Neobladder | A replacement bladder is formed from small intestine and connected to the urethra | Passing urine the natural way; requires bladder training, sometimes self-catheterisation |
| Continent pouch | A reservoir made from bowel with a valve is emptied with a catheter through a small opening at the navel | No bag, but regular catheterisation |
Follow-up care depends on the risk group. With non-muscle-invasive bladder cancer, cystoscopies are at the centre — every few months in the first years, less often later, and for life if the risk is high. After a cystectomy, imaging, kidney function and blood tests are added.³,⁴
Many people with bladder cancer are older and already take medicines for high blood pressure, diabetes or heart rhythm disorders. Over the years, check-ups, instillations and new medicines are added. An up-to-date medication plan and a list of all appointments are then not bureaucracy but safety.
Record check-up dates, results and symptoms and take everything with you to your next follow-up appointment.
Dose reminders, interaction checks, your results over time. Free.
Get started now